Anaemia Postoperative
Conditions
Brief summary
The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL at post-operative day 1
Detailed description
Obtaining a complete blood count (CBC) on post-operative day 1 to assess postoperative hemoglobin levels is routine practice at Cincinnati Urogynecology Associates, TriHealth Inc. after pelvic reconstructive surgery. There is minimal data supporting this practice. Multiple studies throughout the gynecology literature suggest that this is not a necessary or cost effective strategy to assess for postoperative anemia. Most patients who require blood transfusion or reoperation for bleeding will show clinical signs of anemia. The investigators aim to determine if checking a routine CBC results in clinically relevant changes to patient care in women undergoing pelvic reconstructive surgery with vaginal hysterectomy for treatment of pelvic organ prolapse.
Interventions
None listed
Sponsors
TriHealth Inc.
Study design
Observational model
OTHER
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy (CPT 58260, 58262, 58263, 58270, 58290, 58291, 58292, 58294) * At least one of the following vaginal native tissue prolapse repairs * Apical repair with uterosacral ligament suspension (CPT 57283) * Apical repair with sacrospinous ligament fixation (CPT 57282) * Anterior repair (CPT 57240, 57260, 57284, 57285, 57250) * Posterior repair (CPT 45560, 56800, 56810, 57200, 57210, 57250) * Surgery by one of four fellowship trained urogynecologists at TriHealth
Exclusion criteria
* Concomitant surgical procedure by a second surgeon * Malignancy identified at the time of surgery or active malignancy * Cases converted to open hysterectomy or prolapse repairs * Prolapse repair completed robotically * Prolapse repair completed with mesh * Known coagulopathy * Patient on long term preoperative anticoagulant medication (Arixtra, Coumadin, Eliquis, Heparin, Lovenox, Pradaxa, Savaysa, Xarelto)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of Subjects With POD1 Hemoglobin Less Than 10 g/dL | Postop Day 1 |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Vaginal Hysterectomy With Reconstruction All patients who underwent a total vaginal hysterectomy with concurrent vaginal native tissue prolapse repairs performed by one of four fellowship trained urogynecologists at TriHealth between 10/1/2014 and 10/1/2019.
The patients will be identified by CPT codes in the EPIC electronic medical record. | 573 |
| Total | 573 |
Baseline characteristics
| Characteristic | Vaginal Hysterectomy With Reconstruction |
|---|---|
| Age, Continuous | 62.22 years STANDARD_DEVIATION 11.91 |
| Race/Ethnicity, Customized African American | 23 Participants |
| Race/Ethnicity, Customized Asian | 9 Participants |
| Race/Ethnicity, Customized Hispanic | 8 Participants |
| Race/Ethnicity, Customized White | 533 Participants |
| Region of Enrollment United States | 573 Participants |
| Sex: Female, Male Female | 573 Participants |
| Sex: Female, Male Male | 0 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 571 |
| other Total, other adverse events | 0 / 571 |
| serious Total, serious adverse events | 0 / 571 |
Outcome results
Primary
Number of Subjects With POD1 Hemoglobin Less Than 10 g/dL
Time frame: Postop Day 1
| Arm | Measure | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|
| Vaginal Hysterectomy With Reconstruction | Number of Subjects With POD1 Hemoglobin Less Than 10 g/dL | 97 Participants |